# Bioequivalence Study of a Test Capsule Formulation of Fingolimod With the Reference Capsule Formulation of Fingolimod

> **NCT03757338** · PHASE1 · COMPLETED · sponsor: **Asofarma S.A.I. y C.** · enrollment: 33 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Fingolimod Reference Formulation
- **DRUG:** Fingolimod Test Formulation

## Key facts

- **NCT ID:** NCT03757338
- **Lead sponsor:** Asofarma S.A.I. y C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-23
- **Primary completion:** 2016-01-26
- **Final completion:** 2016-01-26
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2018-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03757338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03757338, "Bioequivalence Study of a Test Capsule Formulation of Fingolimod With the Reference Capsule Formulation of Fingolimod". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03757338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*